🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alireza Sharafshah

Guilan University of Medical Sciences

ORCID: 0000-0001-8048-9587

Also affiliated with Hospital Universitário Gaffrée e Guinle, Institute of Behavioral Sciences, Institute of Neurobiology, University of Guilan

NeuroscienceMedicineBiochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.109Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease

Neurology Letters(2024)10.61186/nl.3.2.1
Top 72%
0.109DataRank
Top 72%1 citations

Alireza Sharafshah, Atefeh Ashtari, Sayeh Afshar, Keysan Pour Moghtader, Yasir Waheed +1 more

Papers

Driven by 12 papers — median percentile 28. Top paper: “Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease”.

Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease

Neurology Letters(2024)10.61186/nl.3.2.1
Top 72%
0.109DataRank
Top 72%1 citations

Alireza Sharafshah, Atefeh Ashtari, Sayeh Afshar, Keysan Pour Moghtader, Yasir Waheed +1 more

Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography

Journal of Addiction Psychiatry(2024)10.17756/jap.2024-043
N/A
0DataRank · unranked
10 citations

David Baron, Thomas McLaughlin, Panayotis K Thanos, Catherine A. Dennen, Mauro Ceccanti +6 more

Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy

Journal of Addiction Psychiatry(2024)10.17756/jap.2024-045
N/A
0DataRank · unranked
3 citations

Nicole Jafari, David Baron, Abdalla Bowirrat, Albert Pinhasov, Brian Norling +37 more

The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies

Open Journal of Immunology(2024)10.4236/oji.2024.143006
N/A
0DataRank · unranked
2 citations

Igor Elman, David Han, Colin Hanna, David Baron, Ashim Gupta +21 more

Complex NADASE Infusions Improve Clinical Outcome in Substance Use Disorder: Descriptive Annotation in Fifty Cases

Journal of Addiction Psychiatry(2024)10.17756/jap.2024-046
N/A
0DataRank · unranked
0 citations

Thomas McLaughlin, Kai‐Uwe Lewandrowski, Alireza Sharafshah, Catherine A. Dennen, Panayotis K. Thanos +10 more

Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk

Substance Abuse and Rehabilitation(2025)10.2147/sar.s514931
N/A
0DataRank · unranked
4 citations

Kenneth Blum, Kai‐Uwe Lewandrowski, Mark S. Gold, Alexander P. L. Lewandrowski, Panayotis K. Thanos +7 more

Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia

Frontiers in Public Health(2025)10.3389/fpubh.2025.1594872
N/A
0DataRank · unranked
1 citations

Kenneth Blum, Alexander P. L. Lewandrowski, Panayotis K. Thanos, Albert Pinhasov, Alireza Sharafshah +19 more

Theorizing The Role of Gama Type Endorphins in Schizophrenia and Alcoholism: Promoting Genetic Testing and Attempts at Inducing “Dopamine Homeostasis”

Acta Scientific Neurology(2025)10.31080/asne.2025.08.0817
N/A
0DataRank · unranked
0 citations

Kai Uwe Lewandowski, Alireza Sharafshah, Catherine A. Dennen, Albert Pinhasov, Abdalla Bowirrat +7 more

Addiction Risk Polymorphisms Links Autism Spectrum Disorder with Reward Deficiency Syndrome: Insights from GWAS and Pharmacogenomic Meta Analyses

Preprints.org(2025)10.20944/preprints202507.0381.v1
N/A
0DataRank · unranked
0 citations

Kenneth Blum, Kavya Mohankumar, Milan Makale, Abdalla Bowirrat, Albert Pinhasov +23 more

GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents

Preprints.org(2025)10.20944/preprints202510.1849.v1
N/A
0DataRank · unranked
0 citations

Shaurya Mahajan, Alireza Sharafshah, Keerthy Sunder, Kai‐Uwe Lewandrowski, Kavya Mohankumar +22 more

A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy

Cellular and Molecular Neurobiology(2024)10.1007/s10571-024-01466-5
N/A
0DataRank · unranked
11 citations

Alireza Sharafshah, John C. Elfar, Sergio L. Schmidt, Kenneth Blum, F. Todd Wetzel +1 more

Computational GWAS Meta Meta Analysis Revealing Cross Talk Between Cannabis CNR1 and DRD2 Receptors Optimizing Long-Term Outcomes for Cannabis Use Disorder (CUD) By Enhancing Dopamine Homeostasis Promoting High-Quality Cannabis Medicinals

Research Square(2025)10.21203/rs.3.rs-8140327/v1
N/A
0DataRank · unranked
0 citations

Alireza Sharafshah, Jag Khalsa, Kai-Uwe Lewandrowski, Panayotis K. Thanos, Marco Lindenau +33 more